ES2530417T3 - Dispositivo de apósito para su uso con una cánula o un catéter - Google Patents

Dispositivo de apósito para su uso con una cánula o un catéter Download PDF

Info

Publication number
ES2530417T3
ES2530417T3 ES11736453T ES11736453T ES2530417T3 ES 2530417 T3 ES2530417 T3 ES 2530417T3 ES 11736453 T ES11736453 T ES 11736453T ES 11736453 T ES11736453 T ES 11736453T ES 2530417 T3 ES2530417 T3 ES 2530417T3
Authority
ES
Spain
Prior art keywords
dressing device
amount
cannula
catheter
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11736453T
Other languages
English (en)
Inventor
Keith Real
Peter Donnellan
Beilliu Máire Ni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bard Access Systems Inc
Original Assignee
Bard Access Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bard Access Systems Inc filed Critical Bard Access Systems Inc
Application granted granted Critical
Publication of ES2530417T3 publication Critical patent/ES2530417T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Dispositivo de apósito para heridas para su uso con un dispositivo médico transcutáneo tal como una cánula o un catéter, comprendiendo el dispositivo de apósito una matriz de poliuretano hidrófila flexible, un agente antimicrobiano contenido dentro de la matriz, y un agente hemostásico contenido dentro de la matriz, comprendiendo el agente hemostásico poli(ácido anhidroglucurónico) o sal del mismo en una cantidad para lograr un efecto hemostásico, y comprendiendo el agente antimicrobiano digluconato de clorhexidina en una cantidad para lograr un efecto antimicrobiano sin afectar adversamente a la cicatrización de heridas, en el que el digluconato de clorhexidina está presente en una cantidad de desde el 10 9% hasta el 16% (p/p).
ES11736453T 2010-07-14 2011-07-04 Dispositivo de apósito para su uso con una cánula o un catéter Active ES2530417T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34440310P 2010-07-14 2010-07-14
PCT/IE2011/000034 WO2012007929A1 (en) 2010-07-14 2011-07-04 A dressing device for use with a cannula or a catheter

Publications (1)

Publication Number Publication Date
ES2530417T3 true ES2530417T3 (es) 2015-03-02

Family

ID=44532985

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11736453T Active ES2530417T3 (es) 2010-07-14 2011-07-04 Dispositivo de apósito para su uso con una cánula o un catéter

Country Status (7)

Country Link
US (3) US20130110025A1 (es)
EP (1) EP2600909B1 (es)
JP (1) JP2013535996A (es)
CN (1) CN103260654B (es)
CA (1) CA2819186C (es)
ES (1) ES2530417T3 (es)
WO (1) WO2012007929A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8597253B2 (en) 2007-04-20 2013-12-03 Bard Access Systems Huber needle with safety sheath
US8778387B2 (en) 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
US9248234B2 (en) 2010-09-10 2016-02-02 C. R. Bard, Inc. Systems for isolation of a needle-based infusion set
US20140066894A1 (en) 2010-09-10 2014-03-06 C. R. Bard, Inc. Self-Sealing Pad for a Needle-Based Infusion Set
US10525234B2 (en) * 2010-09-10 2020-01-07 C. R. Bard, Inc. Antimicrobial/haemostatic interface pad for placement between percutaneously placed medical device and patient skin
US9039967B2 (en) 2012-02-06 2015-05-26 Hyprotek, Inc. Antiseptic applicators and packaging techniques
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
EP2752176B1 (de) * 2013-01-08 2024-03-20 BSN medical GmbH Antimikrobiell aktive Wundauflage für Katheterfixierungen
US8961479B2 (en) 2013-03-19 2015-02-24 Biolife, L.L.C. Hemostatic device and method
EP2944565B1 (en) 2014-05-13 2017-09-27 Entrotech, Inc. Erosion protective sleeve
US20150342787A1 (en) * 2014-05-30 2015-12-03 Valarie Williams HAISLEY Invasive medical device dressing and method of application
WO2016004217A1 (en) 2014-07-01 2016-01-07 C.R. Bard, Inc. Antimicrobial/haemostatic interface pad for placement between percutaneously placed medical device and patient skin
ES2921990T3 (es) 2014-09-10 2022-09-05 Bard Inc C R Apósito protector para un dispositivo médico colocado en la piel
CN106146776A (zh) * 2015-04-11 2016-11-23 福州维亚生物科技有限公司 抗菌聚合物及其制备的材料与用途
US20170349313A1 (en) * 2016-06-01 2017-12-07 Centurion Medical Products Corporation Methods for manufacturing non-glass prefilled syringes
CN111093721A (zh) * 2017-09-15 2020-05-01 巴德阿克塞斯系统股份有限公司 用于医疗装置的具有衬垫的抗菌敷料
WO2020043834A1 (en) 2018-08-30 2020-03-05 Stichting Katholieke Universiteit Polyurethane sheet
NL2021630B1 (en) * 2018-09-14 2020-05-06 Stichting Katholieke Univ Polyurethane sheet
US20200100944A1 (en) * 2018-10-02 2020-04-02 Pfm Medical, Inc. Interventional device dressing system
CN114760965A (zh) * 2019-10-08 2022-07-15 康沃特克有限公司 伤口渗出物管理系统
US20210228765A1 (en) * 2020-01-28 2021-07-29 Becton, Dickinson And Company Self-activating catheter insertion site dressing
WO2021263030A1 (en) * 2020-06-26 2021-12-30 Pfm Medical, Inc. Interventional device dressing system
US12575974B2 (en) * 2020-12-30 2026-03-17 Andrew FALCO Snap band dressing devices and methods of use
US20260000547A1 (en) * 2024-06-27 2026-01-01 Andrew MAERTENS Bandage for providing protection and antimicrobial properties to a surgical site with one or more percutaneous pins or wires

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221215A (en) * 1979-04-19 1980-09-09 Isidore Mandelbaum Anchoring and occluding surgical dressing
US4339550A (en) * 1981-01-26 1982-07-13 Carter-Wallace, Inc. Foam products
GB8706116D0 (en) * 1987-03-14 1987-04-15 Smith & Nephew Ass Adhesive dressings
US5064653A (en) * 1988-03-29 1991-11-12 Ferris Mfg. Co. Hydrophilic foam compositions
US5833665A (en) * 1990-06-14 1998-11-10 Integra Lifesciences I, Ltd. Polyurethane-biopolymer composite
GB9123708D0 (en) * 1991-11-07 1992-01-02 Johnson & Johnson Medical Ltd Method of making polyurethane foam
US20030093114A1 (en) * 2001-11-13 2003-05-15 Melvin Levinson Method for effecting hemostasis
US20050003178A1 (en) * 2003-04-21 2005-01-06 Detert James W. Apparatus and methods for the attachment of materials to polyurethane foam, and articles made using them
US8293965B2 (en) * 2006-04-28 2012-10-23 Kimberly-Clark Worldwide, Inc. Antimicrobial site dressings
US20080027365A1 (en) * 2006-06-01 2008-01-31 Huey Raymond J Hemostatic device with oxidized cellulose pad
WO2008010199A2 (en) * 2006-07-18 2008-01-24 Nanopeutics S.R.O. A nanofibre product

Also Published As

Publication number Publication date
CA2819186A1 (en) 2012-01-19
US20130110025A1 (en) 2013-05-02
WO2012007929A1 (en) 2012-01-19
CA2819186C (en) 2018-06-19
JP2013535996A (ja) 2013-09-19
US20200069475A1 (en) 2020-03-05
EP2600909A1 (en) 2013-06-12
CN103260654A (zh) 2013-08-21
EP2600909B1 (en) 2014-11-19
US20220241112A1 (en) 2022-08-04
CN103260654B (zh) 2015-07-22

Similar Documents

Publication Publication Date Title
ES2530417T3 (es) Dispositivo de apósito para su uso con una cánula o un catéter
US10568771B2 (en) Traumatic wound dressing system with conformal cover
ES2846854T3 (es) Composiciones antisépticas que comprenden iones de plata y mentol y usos de las mismas
ES2675879T3 (es) Productos para el cuidado de heridas
MX352822B (es) Composiciones biocidas y métodos para utilizar las mismas.
MX2015009906A (es) Dispositivo de fijacion que tiene una correa y vendaje integral.
MX2012002746A (es) Vendajes medicos antimicrobianos y proteccion de heridas y sitios de cateter.
MX2019007572A (es) Composiciones que comprenden acido acetico y acido hipocloroso y metodos para tratar biopelicula.
UY33502A (es) Formulacion desinfectante y antiseptica con contenido reducido de iodo
MX387712B (es) Composicion y equipos para inhibicion de infeccion microbiana patogena y metodos para usar los mismos.
MY172533A (en) A novel synergistic pharmaceutical composition for tropical applications
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
MX2015011613A (es) Composiciones antimicrobianas-antibiopelicula y metodos para utlizarlas.
ES2836299T3 (es) Composiciones antimicrobianas
ECSP20010477A (es) Composición tópica semisólida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños crónicos de la piel
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
MX365688B (es) Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino.
CL2012003266A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas; composicion farmacéutica y/o dermocosmética antimicrobiana que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo ; metodo para tratar y/o prevenir a un paciente que tiene una infeccion microbiana.
CL2021003317A1 (es) Medicamento y uso del mismo para tratar infecciones bacterianas que involucran una biopelícula.
WO2010018559A3 (en) Formulations for a two-phase management of wound healing and dressings incorporating such formulations.
CO6761349A2 (es) Proteína antimicrobiana
CL2008001282A1 (es) Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria.
MX2015015379A (es) Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos.
RU2010153517A (ru) Противомикробная композиция
EA201991530A1 (ru) Композиции и способы лечения биопленок